Delivering high-performance drug delivery solutions across neurology, immunology, oncology, and mental health.

BioNxt Solutions is a clinical-stage bioscience company focused on redefining how modern medicine is formulated, delivered, and experienced. Our mission is to make therapies safer, smarter, and more effective, improving the lives of patients with neurological, autoimmune, oncological, and mental health conditions.

We operate at the intersection of pharmaceutical science, delivery technology, and translational research. Headquartered in Canada with state-of-the-art research and manufacturing capabilities in Germany, our international footprint and cross-disciplinary team enable us to accelerate innovation and move from lab to clinic with speed and precision.

Designed for Partnerships. Built for Growth.

Platform Thinking

Our strategy is built around scalable drug delivery platforms that unlock therapeutic potential across multiple indications and molecules.

Global Execution

With development and production infrastructure in Germany and strategic partnerships across Europe and North America, we’re positioned to serve global markets from day one.

Agile Business Model

BioNxt prioritizes speed-to-market through repurposing, bioequivalence, and co-development pathways, backed by a growing IP portfolio and industry partnerships.

A Portfolio Aligned With Patient Needs

We focus on three complementary areas that reflect urgent healthcare demand and scientific opportunity:

Precision Drug Delivery

Enhancing drug performance and patient experience through sublingual thin films and transdermal systems.

Targeted Chemotherapy

Building development capabilities to amplify innovations and increase efficiency, effectiveness and accessibility.

Engineered Psychedelics

A proprietary compound library designed for personalized treatment of mental health, neurological, and inflammatory conditions.
Each initiative is chosen not only for its scientific merit, but for its ability to deliver measurable impact: clinically, commercially, and globally.

Our Intellectual Property Advantage

We protect what we create. BioNxt holds a growing number of international patents across its core technologies – ensuring freedom to operate, defensible product offerings, and licensing potential. Our IP spans drug formulations, delivery methods, and therapeutic applications.

Market Opportunity

BioNxt is targeting multi-billion-dollar markets with unmet needs:
Drug Delivery
The global pharmaceutical drug delivery market is valued at $2.15 trillion in 2025 and projected to reach $3.82 trillion by 2035 (CAGR 5.9%). Growth is driven by chronic disease prevalence, new technologies, and demand for patient-friendly and targeted delivery solutions. Source: Future Market Insights
MS and Autoimmune
The MS and autoimmune specialty drug segment is valued at over $25 billion in 2025 and projected to exceed $60 billion by 2034. Growth is fueled by new therapies, improved compliance, and innovative delivery formats such as oral drugs and auto-injectors (based on industry trends and market analyses). Source: Fortune Business Insights
Oncology (Chemotherapy)
The global chemotherapy market is estimated at $10–11 billion in 2025 and expected to reach nearly $20 billion by 2034. There is ongoing demand for safer, more targeted delivery methods, including nanocarriers and combination therapies, to improve efficacy and reduce side effects. Source: Market Research Future
Psychedelic Therapeutics
The psychedelic therapeutics market is valued at $2.2–3.1 billion in 2025 and forecast to grow to $8.5–9.6 billion by 2034. This high-growth segment is driven by clinical validation, regulatory progress, and new delivery formats for mental health and CNS disorders. Source: Data Bridge Market Research

As we advance our pipeline and expand our partnerships, BioNxt remains focused on translating scientific innovation into meaningful therapeutic solutions.

We believe the future of medicine lies in smarter delivery, targeted treatment, and global accessibility – and we’re building the platform to make that future a reality.

Whether through collaboration, licensing, or commercialization, we invite partners, investors, and innovators to join us on this journey.

Looking for investor info?

Get access to our investor package, corportate presentation & more.

CSE:BNXT  FSE:BXT   OTCQB:BNXTF

Visit our investors section to get more information. You’ll get a snapshot of our numbers, learn more about what we do & how we’re striving for impact.

Take me there

Working collaboratively is powerful

Our network of experts and organizations make the difference

Our partnerships include leaders working at the cutting edge of pharmaceutical research and development to drive innovation and disrupt traditional approaches to global health. 

Invest in Xphyto two happy investors talking

Invest in Bionxt, invest in innovation

Learn more about Bionxt’s innovation to impact strategy and get access to Bionxt investor information.

CSE:BNXT  FSE:BXT   OTCQB:BNXTF

Download: Corporate Presentation (PDF)